SYNLAB in the UK & Ireland
This timeline shows the development of SYNLAB UK & Ireland up until the present day, including investments, acquisitions and the launch of new ventures.
Foundation of SYNLAB GmbH – Together with a number of partners, Dr. bartl Wimmer establishes synlab GmbH as an ‘association of freelance laboratory physicians’ in Augsburg
Foundation of Labco SA – A group of French biologists establish Labco SA with 9 groups of laboratories in France. The project had been launched in 2001.
Synergy Health, the award winning and world-leading company in outsourced health-related industries (founded in 1991), purchases Isotron, along with JMJ Laboratories.
JMJ Laboratories renamed Synergy Health Laboratory Services.
Synergy Health purchases Genon Laboratories, a UKAS accredited food testing Laboratory established in 2006 by a team of highly skilled molecular biologists and immunologists.
Labco Spain invested into iPP for access to pathology laboratories in the UK.
The Christie Pathology Partnership (CPP) established, a joint venture between SYNLAB and The Christie NHS Foundation Trust in Manchester.
synlab Clinical Trial Ltd relocated to Hammersmith Medicines Research.
Pathology First formed as a joint venture between iPP, Southend University Hospital NHS Foundation Trust and Basildon and Thurrock University Hospitals NHS Foundation Trust and private sector partners.
Screensafe UK (a laboratory services company founded by the President of the International Association of Forensic Toxicologists 27 years earlier) acquired by Synergy Health Laboratory Services.
Cinven acquires SYNLAB, combining forces in the UK to form SYNLAB group, creating one of the largest European operators of medical diagnostic laboratories, headquartered in Germany.
This follows the completion of the acquisition of Labco, headquartered in France which, combined with SYNLAB, has created the only truly pan-European clinical laboratories business operating across 35 countries and undertaking more than 400 million clinical tests annually across Europe.
HRH The Duke of Kent opened the Pathology First laboratory, marking an important first step towards realising the vision of an innovative and high quality pathology service in South Essex.
SYNLAB acquires Synergy Health Laboratory Services including Genon Laboratories (jointly ‘SHLS’) from Synergy Health.
SYNLAB, the leading provider of medical diagnostic services in Europe, announced the acquisition of Geneius.
SYNLAB, the leading provider of medical diagnostic services in Europe, announced the acquisition of Lextox Drug and Alcohol Testing based in Cardiff.
Lextox Is an ISO 17025 UKAS accredited laboratory specialising in hair drug and alcohol testing.
SYNLAB, the leading provider of medical diagnostic services in Europe, has today announced the acquisition of Veterinary Pathology Group (VPG). The group comprises four laboratories in the UK called TDDS, PTDS, CTDS and Bridge Pathology as well as the laboratory VLSI in the Republic of Ireland.
SYNLAB, the leading medical diagnostic services provider in Europe, announces the signing of an agreement to sell its Analytics & Services (A&S) unit to SGS, the world’s leading inspection, verification, testing and certification company.
SYNLAB has formed a new pathology partnership with Guy’s and St Thomas’, and King’s College Hospital NHS Foundation Trusts to deliver and transform NHS pathology services across South East London.
SYNLAB is now listed on the Frankfurt Stock Exchange.
SYNLAB ESG Report 2021 SYNLAB UK & Ireland’s Environmental, Social and Governance (ESG) Roadmap and Framework
SYNLAB have agreed to sell Veterinary Pathology Group (VPG) to JAB Holding Company.
This is a fantastic prospect for our veterinary business and everyone working there. SYNLAB wish VPG all the very best for the future.